We advised Bioceltix and Infini ASI on the public offering

03.07.2024 Case studies Capital Markets

tygrys

We provided transactional legal services in connection with the public offering of Bioceltix and Infini ASI. We offered comprehensive legal support to Bioceltix, Infini ASI, and the offering managers and bookrunners: mBank Brokerage House, Trigon Investment Banking, and Navigator Brokerage House.

The public offering of newly issued Bioceltix shares and existing Infini ASI shares was conducted via an accelerated book-building process (ABB), exempt from the requirement to prepare a prospectus. It was targeted at (i) qualified investors, (ii) no more than 149 natural or legal persons other than qualified investors, and (iii) investors who purchased shares with a total value of at least EUR 100,000—while maintaining preemptive rights for the company’s existing shareholders.

The PR/IR advisors were CCGroup sp. z o.o. and Hagen Comm sp. z o.o.

The total value of the offering exceeded PLN 60 million.

The transaction involved: Krzysztof Marczuk, Jakub Rowicki, Magdalena Szeplik, and Dawid Marciniak.

Lawyers involved in the project

8. Krzysztof Marczuk 772x1158

Krzysztof Marczuk

Partner
Attorney-at-law

Capital Markets

Krzysztof Marczuk
9. Magdalena Szeplik 772x1158

Magdalena Szeplik

Managing Associate
Advocate

Capital Markets | Corporate law

Magdalena Szeplik
9. Jakub Rowicki 772x1158

Jakub Rowicki

Senior Associate
Advocate

Capital Markets | Mergers and acquisitions (M&A)

Jakub Rowicki

You may also like

07.02.2025

Closing of the transaction of the acquisition of 49.9% in the listed company Shoper S.A. by cyber_Folks S.A.

We are pleased to announce the successful closing of another transaction for one of our key clients, cyber_Folks S.A. Once again, we provided comprehensive legal advice ...

Case studies
Closing of the transaction of the acquisition of 49.9% in the listed company Shoper S.A. by cyber_Folks S.A.

27.01.2025

GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa

As a trusted legal advisor equipped to support clients throughout the entire investment lifecycle, we had the privilege of advising Maabarot Products Ltd., a company own...

Case studies
GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa
Wszystkie case studies

Do you want to be up to date?

Subscribe to the newsletter!

tygrys